Dynorphin: friend or foe?
- 1 August 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Pain
- Vol. 87 (3) , 235-239
- https://doi.org/10.1016/s0304-3959(00)00360-2
Abstract
Pain 87 (2000) 235-239. doi:10.1016/S0304-3959(00)00360-2Received by publisher: 2000-05-22Harvest Date: 2016-01-04 12:22:07DOI: 10.1016/S0304-3959(00)00360-2Page Range: 235-23Keywords
This publication has 26 references indexed in Scilit:
- Dynorphin A (1–13) Neurotoxicity in Vitro: Opioid and Non-Opioid Mechanisms in Mouse Spinal Cord NeuronsExperimental Neurology, 1999
- The kappa opioid agonist GR89 696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathyPain, 1999
- Spinal k1 and k2 opioid binding sites in rats, guinea pigs, monkeys and humansNeuroReport, 1998
- Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1–17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampusNeuropeptides, 1998
- Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranesEuropean Journal of Pharmacology, 1994
- Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysisBrain Research, 1990
- A novel interaction between dynorphin(1–13) and an N-methyl-d-aspartate siteBrain Research, 1988
- Intrathecal dynorphin (1–13) results in an irreversible loss of the tail-flick reflex in ratsBrain Research, 1987
- Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorScience, 1982
- Dynorphin-(1-13), an extraordinarily potent opioid peptide.Proceedings of the National Academy of Sciences, 1979